Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical (DAEDALUS study)

Giacoppo, D; Alfonso, F; Xu, B; Claessen, BEPM; Adriaenssens, T; Jensen, C; Perez-Vizcayno, MJ; Kang, Y; Degenhardt, R; Pleva, L; Baan, J; Cuesta, J; Park, DW; Schunkert, H; Colleran, R; Kukla, P; Jimenez-Quevedo, P; Unverdorben, M; Gao, RL; Naber, CK; Park, SJ; Henriques, JPS; Kastrati, A; Byrne, RA

Byrne, RA (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Dept Cardiovasc Dis, Lazarettstr 36, D-80636 Munich, Germany.; Byrne, RA (corresponding author), Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Marchioninistr 15, D-81377 Munich, Germany.

EUROPEAN HEART JOURNAL, 2020; 41 (38): 3715

Abstract

Aims Consensus is lacking regarding the best treatment for coronary in-stent restenosis (ISR). The two most effective treatments are angioplasty with ......

Full Text Link